Technical Analysis for DTIL - Precision BioSciences, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 12.90 | 0.62% | 0.08 |
DTIL closed up 0.62 percent on Friday, May 31, 2024, on 27 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| 20 DMA Support | Bullish | 0.62% | |
| 200 DMA Support | Bullish | 0.62% | |
| 50 DMA Support | Bullish | 0.62% | |
| Bullish Engulfing | Bullish | 0.62% | |
| Expansion Pivot Buy Setup | Bullish Swing Setup | 0.62% | |
| Pocket Pivot | Bullish Swing Setup | 0.62% | |
| Outside Day | Range Expansion | 0.62% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | 1 day ago |
| Possible NR7 | 1 day ago |
| Expansion Pivot Buy Entry | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Up 3% | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 25.2 |
| 52 Week Low | 8.25 |
| Average Volume | 83,524 |
| 200-Day Moving Average | 11.90 |
| 50-Day Moving Average | 12.12 |
| 20-Day Moving Average | 11.98 |
| 10-Day Moving Average | 12.78 |
| Average True Range | 0.82 |
| RSI (14) | 59.18 |
| ADX | 20.41 |
| +DI | 26.94 |
| -DI | 16.94 |
| Chandelier Exit (Long, 3 ATRs) | 10.99 |
| Chandelier Exit (Short, 3 ATRs) | 12.56 |
| Upper Bollinger Bands | 13.80 |
| Lower Bollinger Band | 10.15 |
| Percent B (%b) | 0.75 |
| BandWidth | 30.44 |
| MACD Line | 0.36 |
| MACD Signal Line | 0.25 |
| MACD Histogram | 0.11 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 13.68 | ||||
| Resistance 3 (R3) | 13.73 | 13.53 | 13.55 | ||
| Resistance 2 (R2) | 13.53 | 13.33 | 13.50 | 13.51 | |
| Resistance 1 (R1) | 13.21 | 13.21 | 13.37 | 13.16 | 13.46 |
| Pivot Point | 13.01 | 13.01 | 13.09 | 12.98 | 13.01 |
| Support 1 (S1) | 12.69 | 12.81 | 12.85 | 12.64 | 12.34 |
| Support 2 (S2) | 12.49 | 12.69 | 12.46 | 12.29 | |
| Support 3 (S3) | 12.17 | 12.49 | 12.25 | ||
| Support 4 (S4) | 12.12 |
